# Du Lin

> Du Lin is a Series B investor at Lucion backing Medical, Biopharma and Health Care. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Lucion](https://shizune.co/investors/profile/lucion)
- Total investments: 3
- Last investment: Jan 2023
- Lead investor: 67%
- Last updated: Aug 2026

Du Lin is a partner of Huaxin Capital, a subsidiary of Luxin Venture Capital.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 67% |
| Biopharma | 1 | 33% |
| Health Care | 1 | 33% |
| Biotechnology | 1 | 33% |
| Clinical Trials | 1 | 33% |

7 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 1 | 33% |
| Series D | 1 | 33% |
| Venture - Series Unknown | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Meidong Huicheng | Meidong Huicheng is a platform for intelligent manufacturing of laboratory automation equipment and consumables. |  | Venture - Series Unknown | Jan 18, 2023 |  |
| Insyce | Inces is an innovative high-tech enterprise focusing on bio-separation technology. | $21.8M | Series B | Jan 04, 2023 |  |
| WeMed | Developer of digital angiography machines intended to be used in the clinical fields of radiology and cardiology. | $46.2M | Series D | Apr 22, 2021 |  |

3 of 3 investments shown.

## Co-investors
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund, 2 deals together
- [Addor Capital](https://shizune.co/investors/profile/addor-capital) — VC Fund, 1 deal together
- [Everest Venture Capital](https://shizune.co/investors/profile/everest-venture-capital) — VC Fund, 1 deal together
- [Granary Capital](https://shizune.co/investors/profile/granary-capital) — VC Fund, 1 deal together
- [HB Ventures](https://shizune.co/investors/profile/hb-ventures-8472) — VC Fund, 1 deal together
- [Jintou Zhiyuan](https://shizune.co/investors/profile/jintou-zhiyuan) — VC Fund, 1 deal together

## About Lucion

VC Fund · Jinan, China

Lucion is an influential professional venture capital institute.

2 contacts available at Lucion.

| Name | Title | Profile |
| --- | --- | --- |
| Bozhe Liu | General Manager & Director | https://shizune.co/investors/profile/bozhe-liu |
| Du Lin | Partner | https://shizune.co/investors/profile/du-lin-e8e2 |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Du Lin invest in?

Du Lin invests primarily in Medical, Biopharma and Health Care startups, most often at Series B and Series D stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Du Lin last invest?

The most recent investment recorded for Du Lin closed in Jan 2023. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co